title: Treatment of hepatitis C in a lung transplant recipient with sofosbuvir and daclatasvir.
authors.affiliation: Division of Infectious Diseases University of Alberta, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Karen
authors.initials: K
authors.lastname: Doucette
authors.affiliation: Hepatitis Support Program, Alberta Health Services, Edmonton, Alberta, Canada.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Sumner
authors.affiliation: Division of Pulmonary Medicine and Lung Transplant Program, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Justin
authors.initials: J
authors.lastname: Weinkauf
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D012131:Respiratory Insufficiency / Q000601:surgery*; D066027:Transplant Recipients; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents